HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

SPNT

SiriusPoint Ltd. (NYSE)

Financial Services — Insurance - Reinsurance

SiriusPoint Ltd. provides multi-line reinsurance and insurance products and services worldwide. It operates in four segments: Global P&C Programs, Global Reinsurance, Global Accident & Health, and London Market Specialty. Global P&C Programs segment offers programs space, by further strengthening its offering to clients and distribution partners globally. , Global Reinsurance segment provides casualty, property, and other specialties, such as proportional and excess of loss, treaty and facultative, aviation and space, marine and energy and, credit to insurance and reinsurance companies, government entities, and other risk bearing vehicles. London Market Specialty segment provides London casualty, energy, property, and marine leaders services. It provides accident and health, property and casualty, aviation and space, credit, surety, marine and energy, and mortgage. It offers medical insurance products, trip cancellation programs, medical management services, and 24/7 emergency medical and travel assistance services. The company was formerly known as Third Point Reinsurance Ltd. and changed its name to SiriusPoint Ltd. in February 2021. SiriusPoint Ltd. was incorporated in 2011 and is headquartered in Pembroke, Bermuda.

None 3 analysts
$23.77
+$0.02 (+0.08%)
Target: $27.00 (13.6%)
Sign in to add SPNT to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$2.79B
P/E Ratio (TTM)5.99
Forward P/E8.60
EPS (TTM)$3.97
Dividend Yield-
Profit Margin16.51%
Revenue Growth6.50%
ROE23.11%
Debt/Equity30.52
Recommendation None
Analyst Target$27.00
Analysts3
Indexes NYSE

Technical Indicators

RSI (14)51.0
Beta0.62
SMA 20-
SMA 40-
52-Week High$24.58
52-Week Low$17.17
50-Day Avg$22.96
200-Day Avg$20.99
Avg Volume801.0K
Volume5.0K

Performance Analysis

BULLISH

SPNT shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 89% of its 52-week range.
~ RSI at 51.0 is in neutral territory.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
+ P/E of 6.0 suggests the stock may be undervalued.
~ Modest revenue growth of 6.5% year-over-year.
~ Wall Street consensus is "none" from 3 analysts.
+ Average analyst target of $27.00 implies 13.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:32 UTC

Back to Screener Export Report